At what stage of ovarian cancer is para-aortic lymph node involvement typically indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Para-aortic Lymph Node Involvement in Ovarian Cancer Staging

Para-aortic lymph node involvement is classified as Stage IIIC in ovarian cancer according to the FIGO staging system, unless it is the only site of metastasis outside the pelvis (without peritoneal carcinomatosis), in which case it is classified as Stage IIIA1 in the revised 2014 FIGO staging system. 1

FIGO Staging Classification and Para-aortic Nodes

Stage IIIA1 (2014 Revised FIGO System)

  • Metastases involving retroperitoneal lymph nodes (pelvic and para-aortic) in the absence of peritoneal spread above the pelvic brim or distant metastases 1
  • Further subdivided into:
    • Stage IIIA1(i): nodal metastases ≤10 mm 1
    • Stage IIIA1(ii): nodal metastases >10 mm 1

Stage IIIC (Traditional Classification)

  • In the traditional FIGO staging system, para-aortic lymph node metastases were classified as Stage IIIC 1
  • Defined as "peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis" 1

Incidence of Para-aortic Lymph Node Involvement by Stage

  • Stage I: 6-18.2% of patients have para-aortic node metastases 2, 3
  • Stage II: 20% of patients have para-aortic node metastases 3
  • Stage III: 41.9-68% of patients have para-aortic node metastases 2, 3
  • Stage IV: 66.7% of patients have para-aortic node metastases 3

Pattern of Lymphatic Spread

  • The highest frequency of para-aortic node involvement is found in:
    • Upper left para-aortic region (32% of patients) 4
    • Between vena cava inferior and abdominal aorta (36% of patients) 4
  • Most frequent groups for nodal metastases are paracaval (56%), external iliac (60%), and obturator (55%) 5
  • In Stage I, lymphatic spread is typically ipsilateral to the tumor 2
  • In Stage III, metastases are also observed in intercavoaortic, retrocaval, retroaortic, internal iliac, and presacral nodes 2

Clinical Significance

  • Patients with Stage IIIC ovarian cancer based solely on retroperitoneal lymph node metastasis (without peritoneal carcinomatosis) have significantly better survival (58-84%) compared to those with macroscopic peritoneal carcinomatosis (18-36%) 6
  • This survival difference led to the 2014 FIGO staging revision that created the Stage IIIA1 category 1
  • Para-aortic lymphadenectomy is an essential component of comprehensive surgical staging for ovarian cancer 1

Surgical Considerations

  • Pelvic and para-aortic lymph node dissection should be performed as part of comprehensive surgical staging 1
  • In apparent Stage I disease, 15% of patients may have microscopically positive lymph nodes 1
  • Bilateral pelvic and para-aortic lymphadenectomy is necessary for proper staging and treatment of micrometastases, even in patients with unilateral tumors 5
  • Para-aortic lymph node dissection should extend up to the renal veins 1

Important Caveats

  • Clinical assessment and intraoperative findings cannot reliably predict para-aortic lymph node involvement 4
  • Pelvic node status alone is not a reliable predictor of para-aortic node status - studies show sensitivity of only 50% in ovarian cancer confined to the pelvis and 73% in more advanced disease 4
  • In 20% of cases, para-aortic nodes may be positive when pelvic nodes are negative 5
  • Histologic grade correlates with likelihood of nodal involvement - Grade 3 tumors have the highest incidence of nodal metastases 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2007

Research

Ovarian cancer: lymph node metastases.

European journal of gynaecological oncology, 2009

Research

Lymph node-positive stage IIIC ovarian cancer: a separate entity?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.